Search

Your search keyword '"Tabibian, James H."' showing total 261 results
Start Over Author "Tabibian, James H." Search Limiters Peer Reviewed
261 results on '"Tabibian, James H."'

6. Gastrointestinal Manifestations of Coronavirus Disease 2019 Across the United States: A Multicenter Cohort Study

Author

Patel, Ankur P., Sanders, Troy K., Prakash, Preeti, Law, Jade, Alvencar, Sujay, Choi, Alyssa, Shah, Janaki, Patel, Karishma, Srivoleti, Padmavathi, Chauhan, Kirtan, Weissman, Simcha, Holzwanger, Erik, Dhingra, Rohit, Nguyen, Michelle, Kim, Daniel, Sidhu, Tahnee, Stallwood, Christopher, Dickstein, Aaron, Parekh, Nimisha, Altayar, Osama, Ciorba, Matthew A., Yu, Jessica, Chen, Lea Ann, Tabibian, James H., and Limketkai, Berkeley N.

Published
2022
Full Text
View/download PDF

20. Setting minimum standards for training in EUS and ERCP: results from a prospective multicenter study evaluating learning curves and competence among advanced endoscopy trainees

Author

Wani, Sachin, Han, Samuel, Simon, Violette, Hall, Matthew, Early, Dayna, Aagaard, Eva, Abidi, Wasif M., Banerjee, Subhas, Baron, Todd H., Bartel, Michael, Bowman, Erik, Brauer, Brian C., Buscaglia, Jonathan M., Carlin, Linda, Chak, Amitabh, Chatrath, Hemant, Choudhary, Abhishek, Confer, Bradley, Coté, Gregory A., Das, Koushik K., DiMaio, Christopher J., Dries, Andrew M., Edmundowicz, Steven A., El Chafic, Abdul Hamid, El Hajj, Ihab, Ellert, Swan, Ferreira, Jason, Gamboa, Anthony, Gan, Ian S., Gangarosa, Lisa, Gannavarapu, Bhargava, Gordon, Stuart R., Guda, Nalini M., Hammad, Hazem T., Harris, Cynthia, Jalaj, Sujai, Jowell, Paul, Kenshil, Sana, Klapman, Jason, Kochman, Michael L., Komanduri, Sri, Lang, Gabriel, Lee, Linda S., Loren, David E., Lukens, Frank J., Mullady, Daniel, Muthusamy, Raman V., Nett, Andrew S., Olyaee, Mojtaba S., Pakseresht, Kavous, Perera, Pranith, Pfau, Patrick, Piraka, Cyrus, Poneros, John M., Rastogi, Amit, Razzak, Anthony, Riff, Brian, Saligram, Shreyas, Scheiman, James M., Schuster, Isaiah, Shah, Raj J., Sharma, Rishi, Spaete, Joshua P., Singh, Ajaypal, Sohail, Muhammad, Sreenarasimhaiah, Jayaprakash, Stevens, Tyler, Tabibian, James H., Tzimas, Demetrios, Uppal, Dushant S., Urayama, Shiro, Vitterbo, Domenico, Wang, Andrew Y., Wassef, Wahid, Yachimski, Patrick, Zepeda-Gomez, Sergio, Zuchelli, Tobias, and Keswani, Rajesh N.

Published
2019
Full Text
View/download PDF

23. Competence in Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatography, From Training Through Independent Practice

Author

Wani, Sachin, Keswani, Rajesh N., Han, Samuel, Aagaard, Eva M., Hall, Matthew, Simon, Violette, Abidi, Wasif M., Banerjee, Subhas, Baron, Todd H., Bartel, Michael, Bowman, Erik, Brauer, Brian C., Buscaglia, Jonathan M., Carlin, Linda, Chak, Amitabh, Chatrath, Hemant, Choudhary, Abhishek, Confer, Bradley, Coté, Gregory A., Das, Koushik K., DiMaio, Christopher J., Dries, Andrew M., Edmundowicz, Steven A., El Chafic, Abdul Hamid, El Hajj, Ihab, Ellert, Swan, Ferreira, Jason, Gamboa, Anthony, Gan, Ian S., Gangarosa, Lisa M., Gannavarapu, Bhargava, Gordon, Stuart R., Guda, Nalini M., Hammad, Hazem T., Harris, Cynthia, Jalaj, Sujai, Jowell, Paul S., Kenshil, Sana, Klapman, Jason, Kochman, Michael L., Komanduri, Srinadh, Lang, Gabriel, Lee, Linda S., Loren, David E., Lukens, Frank J., Mullady, Daniel, Muthusamy, V. Raman, Nett, Andrew S., Olyaee, Mojtaba S., Pakseresht, Kavous, Perera, Pranith, Pfau, Patrick, Piraka, Cyrus, Poneros, John M., Rastogi, Amit, Razzak, Anthony, Riff, Brian, Saligram, Shreyas, Scheiman, James M., Schuster, Isaiah, Shah, Raj J., Sharma, Rishi, Spaete, Joshua P., Singh, Ajaypal, Sohail, Muhammad, Sreenarasimhaiah, Jayaprakash, Stevens, Tyler, Tabibian, James H., Tzimas, Demetrios, Uppal, Dushant S., Urayama, Shiro, Vitterbo, Domenico, Wang, Andrew Y., Wassef, Wahid, Yachimski, Patrick, Zepeda-Gomez, Sergio, Zuchelli, Tobias, and Early, Dayna

Published
2018
Full Text
View/download PDF

43. Clinical Features and Outcomes of Patients with Pancreaticobiliary Malignancies in Los Angeles County and Their Association with CA 19-9 Levels.

Author

Law, Jade, Trieu, Harry, Kaleka, Guneet, Turkiewicz, Joanna, Palmer, Samantha, Lee, Jennifer M., Chen, Kathryn T., and Tabibian, James H.

Subjects
PANCREATIC tumors, EVALUATION of medical care, BILE duct tumors, CONFIDENCE intervals, AGE distribution, RETROSPECTIVE studies, REGRESSION analysis, EARLY detection of cancer, CANCER patients, SEX distribution, KAPLAN-Meier estimator, SURVIVAL analysis (Biometry), DESCRIPTIVE statistics, TUMOR antigens, STATISTICAL sampling, BODY mass index, ODDS ratio, TUMOR markers, DATA analysis software, PROPORTIONAL hazards models
Abstract

Simple Summary: Pancreaticobiliary malignancies (PBMs) are a leading cause of cancer-related deaths worldwide, with 611,722 deaths reported in 2020. Serum carbohydrate antigen (CA) 19-9 is a tumor marker commonly used clinically in the management of patients with PBMs. Several studies have demonstrated the utility of CA 19-9 levels as a marker of diagnosis, prognosis, and surveillance. However, few studies have specifically examined clinical presentations and outcomes in patients with low or undetectable CA 19-9 levels. The aim of our retrospective study was to examine the clinical features and outcomes of patients with tissue-proven cases of PBMs who had low CA 19-9 levels at diagnosis and compare them to those with normal and elevated CA 19-9 levels. Given the morbidity and mortality of PBMs, a better understanding of the role of CA 19-9 could lead to the tailored management of disease and, thus, improved outcomes in those with low CA 19-9 levels. Although CA 19-9 is a commonly used tumor marker in the management of PBMs, the literature describing outcomes in patients with PBMs who have undetectable or low (hereinafter "low") CA 19-9 levels remains scarce. In this study, we sought to compare clinical features and outcomes in patients with PBMs and low CA 19-9 levels to those with normal and elevated CA 19-9 levels. Methods: We retrospectively collected data on patients with biopsy-confirmed PBMs and stratified patients into categories based on their CA 19-9 level at diagnosis. Survival curves were estimated for patients in each of the three aforementioned CA 19-9 groups using the Kaplan–Meier method and compared using a Cox proportional hazards regression model. Results: Of the 283 patients identified, 23 (8.1%) had low, 70 (24.7%) had normal, and 190 (67.1%) had elevated CA 19-9 levels. After controlling for sex, age, BMI, the presence of metastases at the time of diagnosis, and treatment with curative intent, the hazard ratio for death in the elevated CA 19-9 group compared to the low CA 19-9 group was 1.993 (95% CI 1.089–3.648; p = 0.025). Conclusion: The elevated CA 19-9 level compared to the low CA 19-9 level and the presence of metastases were associated with an increased hazard of death, while treatment with curative intent was associated with a decreased hazard of death. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results